Analysis of the Correct Answer (Option 4)
Reports of severe lower back pain and difficulty walking that started acutely (2 weeks ago) are the most significant findings to report immediately. This presentation is a classic red flag for metastatic epidural spinal cord compression (MESCC), a time-sensitive oncologic emergency. In a patient with suspected prostate cancer, the axial skeleton, particularly the spine, is a common site for metastasis. Tumor growth within the vertebral body can extend into the epidural space, compressing the spinal cord or nerve roots.
The pathophysiology involves mechanical compression and vascular compromise leading to cord edema, ischemia, and potentially irreversible neurological damage. The cited case report explicitly states that Loss of motor function due to metastatic epidural spinal cord compression (MESCC) is a time-sensitive oncologic emergency. Rapid recognition and decompression are essential [2]. The acute onset of gait disturbance and severe pain signals a progressing lesion. A Delphi study on spinal cord compression outcomes reinforces that management decisions are highly individualized and time-dependent due to the risk of permanent neurological deficit . Delaying reporting by even hours can mean the difference between a patient who walks again and one who suffers permanent paraplegia.
Why the Other Options Are Lower Priority
Option 1: Complaints of urinary frequency and nocturia for the past 6 months are classic, chronic symptoms of bladder outlet obstruction from an enlarged prostate. While important to document and report, a 6-month history indicates a non-emergent, gradual process. This does not represent an immediate threat to life or limb.
Option 2: A digital rectal examination (DRE) revealing a firm, enlarged prostate gland is a key clinical finding that raises suspicion for prostate cancer and warrants further diagnostic workup. However, it is an expected physical exam finding during the evaluation process, not an acute change requiring immediate provider notification over a potential cord compression.
Option 3: A PSA level of 8.5 ng/mL is elevated above the normal range of 0-4 ng/mL and supports the need for a cancer workup. However, PSA elevation is a laboratory value used for screening and monitoring. An isolated elevated PSA, without signs of acute metastatic complication, does not constitute an emergency. The research on skeletal events in metastatic prostate cancer highlights that while bone metastases are a significant complication, the predictive factors and management with agents like denosumab are part of a longer-term treatment strategy, not an immediate response to a single lab value .
Nursing Implications for MESCC
The nurse's immediate priority is to recognize the clinical triad of MESCC: new or worsening back pain, motor weakness (difficulty walking), and potential sensory or autonomic dysfunction. Upon identifying these symptoms, the nurse must immediately notify the healthcare provider to facilitate urgent MRI imaging and prompt neurosurgical or radiation oncology consultation. A single-surgeon cohort study on metastatic spinal disease confirms that surgical intervention plays a vital role in preserving neurological function and quality of life for selected patients, emphasizing the need for rapid assessment . The nurse also initiates strict spine precautions, including keeping the patient flat on a firm surface and using a log-roll technique for any movement, to prevent further cord injury while awaiting definitive treatment.
New or worsening back pain in a patient with known or suspected cancer is a red flag for metastatic epidural spinal cord compression (MESCC). The axial skeleton is a common site for prostate cancer metastasis.
Immediately report any acute onset of severe back pain, gait disturbance, lower extremity weakness, or changes in bowel/bladder function. These symptoms suggest progressing neurological compromise.
MESCC is a time-sensitive emergency. Delayed recognition and treatment can lead to irreversible paralysis. The goal is to intervene within 24 to 48 hours of symptom onset for the best neurological outcome.
학습 참고용입니다. 실제 임상은 최신 지침과 소속 기관 프로토콜을 따르세요.